BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Van Norman GA. Limitations of Animal Studies for Predicting Toxicity in Clinical Trials: Is it Time to Rethink Our Current Approach? JACC Basic Transl Sci 2019;4:845-54. [PMID: 31998852 DOI: 10.1016/j.jacbts.2019.10.008] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 13.7] [Reference Citation Analysis]
Number Citing Articles
1 Zheng Y, Li R, Fan X. Targeting Oxidative Stress in Intracerebral Hemorrhage: Prospects of the Natural Products Approach. Antioxidants 2022;11:1811. [DOI: 10.3390/antiox11091811] [Reference Citation Analysis]
2 Liu X, Xie X, Luo M, Zhao Y, Li M, Peng F, Peng C. The synergistic compatibility mechanisms of fuzi against chronic heart failure in animals: A systematic review and meta-analysis. Front Pharmacol 2022;13:954253. [DOI: 10.3389/fphar.2022.954253] [Reference Citation Analysis]
3 Niazi SK. Molecular Biosimilarity—An AI-Driven Paradigm Shift. IJMS 2022;23:10690. [DOI: 10.3390/ijms231810690] [Reference Citation Analysis]
4 Amorós MA, Choi ES, Cofré AR, Dokholyan NV, Duzzioni M. Motor neuron-derived induced pluripotent stem cells as a drug screening platform for amyotrophic lateral sclerosis. Front Cell Dev Biol 2022;10:962881. [DOI: 10.3389/fcell.2022.962881] [Reference Citation Analysis]
5 de Sá AGC, Long Y, Portelli S, Pires DEV, Ascher DB. toxCSM: comprehensive prediction of small molecule toxicity profiles. Brief Bioinform 2022:bbac337. [PMID: 35998885 DOI: 10.1093/bib/bbac337] [Reference Citation Analysis]
6 van der Zalm AJ, Barroso J, Browne P, Casey W, Gordon J, Henry TR, Kleinstreuer NC, Lowit AB, Perron M, Clippinger AJ. A framework for establishing scientific confidence in new approach methodologies. Arch Toxicol. [DOI: 10.1007/s00204-022-03365-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Afewerki S, Stocco TD, Rosa da Silva AD, Aguiar Furtado AS, Fernandes de Sousa G, Ruiz-Esparza GU, Webster TJ, Marciano FR, Strømme M, Zhang YS, Lobo AO. In vitro high-content tissue models to address precision medicine challenges. Mol Aspects Med 2022;:101108. [PMID: 35987701 DOI: 10.1016/j.mam.2022.101108] [Reference Citation Analysis]
8 López-Canosa A, Pérez-Amodio S, Engel E, Castaño O. Microfluidic 3D Platform to Evaluate Endothelial Progenitor Cell Recruitment by Bioactive Materials. Acta Biomater 2022:S1742-7061(22)00496-2. [PMID: 35981686 DOI: 10.1016/j.actbio.2022.08.019] [Reference Citation Analysis]
9 Azkona G, Sanchez-Pernaute R. Mice in translational neuroscience: What R we doing? Prog Neurobiol 2022;217:102330. [PMID: 35872220 DOI: 10.1016/j.pneurobio.2022.102330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Cassotta M, Bartnicka JJ, Pistollato F, Parvatam S, Weber T, D'alessandro V, Bastos LF, Coecke S. A worldwide survey on the use of animal‐derived materials and reagents in scientific experimentation. Engineering in Life Sciences. [DOI: 10.1002/elsc.202100167] [Reference Citation Analysis]
11 Salazar-terreros MJ, Vernot J. In Vitro and In Vivo Modeling of Normal and Leukemic Bone Marrow Niches: Cellular Senescence Contribution to Leukemia Induction and Progression. IJMS 2022;23:7350. [DOI: 10.3390/ijms23137350] [Reference Citation Analysis]
12 Kim H, Im I, Jeon JS, Kang E, Lee H, Jo S, Kim J, Woo D, Choi YJ, Kim HJ, Han J, Lee B, Kim J, Kim SK, Park H. Development of human pluripotent stem cell-derived hepatic organoids as an alternative model for drug safety assessment. Biomaterials 2022;286:121575. [DOI: 10.1016/j.biomaterials.2022.121575] [Reference Citation Analysis]
13 Pistollato F, Bal-Price A, Coecke S, Parvatam S, Pamies D, Czysz K, Hao J, Kee K, Teo AKK, Niu S, Wilmes A, Smirnova L, Freund C, Mummery C, Stacey G. Quality criteria for in vitro human pluripotent stem cell-derived models of tissue-based cells. Reprod Toxicol 2022;112:36-50. [PMID: 35697279 DOI: 10.1016/j.reprotox.2022.06.003] [Reference Citation Analysis]
14 Wei Y, Amend B, Todenhöfer T, Lipke N, Aicher WK, Fend F, Stenzl A, Harland N. Urinary Tract Tumor Organoids Reveal Eminent Differences in Drug Sensitivities When Compared to 2-Dimensional Culture Systems. Int J Mol Sci 2022;23:6305. [PMID: 35682984 DOI: 10.3390/ijms23116305] [Reference Citation Analysis]
15 Cui B, Cho S. Blood-brain barrier-on-a-chip for brain disease modeling and drug testing. BMB Rep 2022;55:213-9. [DOI: 10.5483/bmbrep.2022.55.5.043] [Reference Citation Analysis]
16 Brooks IR, Garrone CM, Kerins C, Kiar CS, Syntaka S, Xu JZ, Spagnoli FM, Watt FM. Functional genomics and the future of iPSCs in disease modeling. Stem Cell Reports 2022;17:1033-47. [PMID: 35487213 DOI: 10.1016/j.stemcr.2022.03.019] [Reference Citation Analysis]
17 Philips CA, Patwa AK, Hanchanale P, Kalal C, Bishnu S, Sharma M; Liver Research Club India (LIVERECI). Reply. Hepatol Commun 2022. [PMID: 35535027 DOI: 10.1002/hep4.1982] [Reference Citation Analysis]
18 Tutty MA, Movia D, Prina-Mello A. Three-dimensional (3D) liver cell models - a tool for bridging the gap between animal studies and clinical trials when screening liver accumulation and toxicity of nanobiomaterials. Drug Deliv Transl Res 2022. [PMID: 35507131 DOI: 10.1007/s13346-022-01147-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Teleanu RI, Preda MD, Niculescu A, Vladâcenco O, Radu CI, Grumezescu AM, Teleanu DM. Current Strategies to Enhance Delivery of Drugs across the Blood–Brain Barrier. Pharmaceutics 2022;14:987. [DOI: 10.3390/pharmaceutics14050987] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
20 Gore M, Tiwari A, Jahagirdar D, Narayanasamy A, Jain R, Dandekar P. Three-dimensional spheroids of choroid-retinal vascular endothelial cells as an in-vitro model for diabetic retinopathy: Proof-of-concept investigation. Current Research in Pharmacology and Drug Discovery 2022. [DOI: 10.1016/j.crphar.2022.100111] [Reference Citation Analysis]
21 Galligioni V, Movia D, Ruiz-pérez D, Sánchez-morgado JM, Prina-mello A. The Case for Modernizing Biomedical Research in Ireland through the Creation of an Irish 3Rs Centre. Animals 2022;12:1078. [DOI: 10.3390/ani12091078] [Reference Citation Analysis]
22 Niazi SK. The Coming of Age of Biosimilars: A Personal Perspective. Biologics 2022;2:107-27. [DOI: 10.3390/biologics2020009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
23 Shou Y, Johnson SC, Quek YJ, Li X, Tay A. Integrative lymph node-mimicking models created with biomaterials and computational tools to study the immune system. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100269] [Reference Citation Analysis]
24 Marshall LJ, Constantino H, Seidle T. Phase-In to Phase-Out—Targeted, Inclusive Strategies Are Needed to Enable Full Replacement of Animal Use in the European Union. Animals 2022;12:863. [DOI: 10.3390/ani12070863] [Reference Citation Analysis]
25 Doak SH, Clift MJD, Costa A, Delmaar C, Gosens I, Halappanavar S, Kelly S, Pejinenburg WJGM, Rothen-Rutishauser B, Schins RPF, Stone V, Tran L, Vijver MG, Vogel U, Wohlleben W, Cassee FR. The Road to Achieving the European Commission's Chemicals Strategy for Nanomaterial Sustainability-A PATROLS Perspective on New Approach Methodologies. Small 2022;:e2200231. [PMID: 35324067 DOI: 10.1002/smll.202200231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Rizki-Safitri A, Tokito F, Nishikawa M, Tanaka M, Maeda K, Kusuhara H, Sakai Y. Prospect of in vitro Bile Fluids Collection in Improving Cell-Based Assay of Liver Function. Front Toxicol 2021;3:657432. [PMID: 35295147 DOI: 10.3389/ftox.2021.657432] [Reference Citation Analysis]
27 Zoio P, Lopes-ventura S, Oliva A. Biomimetic Full-Thickness Skin-on-a-Chip Based on a Fibroblast-Derived Matrix. Micro 2022;2:191-211. [DOI: 10.3390/micro2010013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
28 Huang S, Jiang C, Mughal MJ, Wang G, Xing F. An In Vivo Fluorescence Resonance Energy Transfer-Based Imaging Platform for Targeted Drug Discovery and Cancer Therapy. Front Bioeng Biotechnol 2022;10:839078. [PMID: 35237583 DOI: 10.3389/fbioe.2022.839078] [Reference Citation Analysis]
29 Shin HK, Florean O, Hardy B, Doktorova T, Kang M. Semi-automated approach for generation of biological networks on drug-induced cholestasis, steatosis, hepatitis, and cirrhosis. Toxicol Res . [DOI: 10.1007/s43188-022-00124-6] [Reference Citation Analysis]
30 Dong S, Nessler I, Kopp A, Rubahamya B, Thurber GM. Predictive Simulations in Preclinical Oncology to Guide the Translation of Biologics. Front Pharmacol 2022;13:836925. [DOI: 10.3389/fphar.2022.836925] [Reference Citation Analysis]
31 Kenny SE, Antaw F, Locke WJ, Howard CB, Korbie D, Trau M. Next-Generation Molecular Discovery: From Bottom-Up In Vivo and In Vitro Approaches to In Silico Top-Down Approaches for Therapeutics Neogenesis. Life 2022;12:363. [DOI: 10.3390/life12030363] [Reference Citation Analysis]
32 Doi K, Kimura H, Matsunaga YT, Fujii T, Nangaku M. Glomerulus-on-a-Chip: Current Insights and Future Potential Towards Recapitulating Selectively Permeable Filtration Systems. IJNRD 2022;Volume 15:85-101. [DOI: 10.2147/ijnrd.s344725] [Reference Citation Analysis]
33 Lin K, Yang J, Ho P, Yen C, Huang H, Lin H, Chung J, Chen G. Development of an alveolar chip model to mimic respiratory conditions due to fine particulate matter exposure. Applied Materials Today 2022;26:101281. [DOI: 10.1016/j.apmt.2021.101281] [Reference Citation Analysis]
34 Cuanalo-Contreras K, Benkmann D. Towards More Human and Humane Testing: The Role of the Device Supplier Industry. Altern Lab Anim 2022;:2611929211073132. [PMID: 35184611 DOI: 10.1177/02611929211073132] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Ashok A, Andrabi SS, Mansoor S, Kuang Y, Kwon BK, Labhasetwar V. Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation. Antioxidants 2022;11:408. [DOI: 10.3390/antiox11020408] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
36 Jiang Y, Lin W, Zhu L. Targeted Drug Delivery for the Treatment of Blood Cancers. Molecules 2022;27:1310. [PMID: 35209102 DOI: 10.3390/molecules27041310] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Floyd ZE, Ribnicky DM, Raskin I, Hsia DS, Rood JC, Gurley BJ. Designing a Clinical Study With Dietary Supplements: It's All in the Details. Front Nutr 2022;8:779486. [DOI: 10.3389/fnut.2021.779486] [Reference Citation Analysis]
38 Youhanna S, Kemas AM, Preiss L, Zhou Y, Shen JX, Cakal SD, Paqualini FS, Goparaju SK, Shafagh RZ, Lind JU, Sellgren CM, Lauschke VM. Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development-Current State-of-the-Art and Future Perspectives. Pharmacol Rev 2022;74:141-206. [PMID: 35017176 DOI: 10.1124/pharmrev.120.000238] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Cerimi K, Jäckel U, Meyer V, Daher U, Reinert J, Klar S. In Vitro Systems for Toxicity Evaluation of Microbial Volatile Organic Compounds on Humans: Current Status and Trends. JoF 2022;8:75. [DOI: 10.3390/jof8010075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Lee SY, Lee DY, Kang JH, Jeong JW, Kim JH, Kim HW, Oh DH, Kim J, Rhim S, Kim G, Kim HS, Jang YD, Park Y, Hur SJ. Alternative experimental approaches to reduce animal use in biomedical studies. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103131] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Demarque DP, Espindola LS. Challenges, Advances and Opportunities in Exploring Natural Products to Control Arboviral Disease Vectors. Front Chem 2021;9:779049. [PMID: 34869227 DOI: 10.3389/fchem.2021.779049] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Asghar S, Khan IU, Salman S, Khalid SH, Ashfaq R, Vandamme TF. Plant-derived nanotherapeutic systems to counter the overgrowing threat of resistant microbes and biofilms. Adv Drug Deliv Rev 2021;179:114019. [PMID: 34699940 DOI: 10.1016/j.addr.2021.114019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Tajeddin A, Mustafaoglu N. Design and Fabrication of Organ-on-Chips: Promises and Challenges. Micromachines (Basel) 2021;12:1443. [PMID: 34945293 DOI: 10.3390/mi12121443] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
44 Matsui T, Shinozawa T. Human Organoids for Predictive Toxicology Research and Drug Development. Front Genet 2021;12:767621. [PMID: 34790228 DOI: 10.3389/fgene.2021.767621] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
45 Morotti S, Liu C, Hegyi B, Ni H, Fogli Iseppe A, Wang L, Pritoni M, Ripplinger CM, Bers DM, Edwards AG, Grandi E. Quantitative cross-species translators of cardiac myocyte electrophysiology: Model training, experimental validation, and applications. Sci Adv 2021;7:eabg0927. [PMID: 34788089 DOI: 10.1126/sciadv.abg0927] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
46 Gage M, Putra M, Gomez-Estrada C, Golden M, Wachter L, Gard M, Thippeswamy T. Differential Impact of Severity and Duration of Status Epilepticus, Medical Countermeasures, and a Disease-Modifier, Saracatinib, on Brain Regions in the Rat Diisopropylfluorophosphate Model. Front Cell Neurosci 2021;15:772868. [PMID: 34720886 DOI: 10.3389/fncel.2021.772868] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
47 Hines DE, Zhang J, Chang X, Bell SM, Monica Lee K. Application of open-source PBPK models in rat-to-human pharmacokinetic extrapolation of oral nicotine exposure. Computational Toxicology 2021;20:100182. [DOI: 10.1016/j.comtox.2021.100182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Walczak PA, Perez-Esteban P, Bassett DC, Hill EJ. Modelling the central nervous system: tissue engineering of the cellular microenvironment. Emerg Top Life Sci 2021;5:507-17. [PMID: 34524411 DOI: 10.1042/ETLS20210245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
49 Kalla D, Flisikowski K, Yang K, Sangüesa LB, Kurome M, Kessler B, Zakhartchenko V, Wolf E, Lickert H, Saur D, Schnieke A, Flisikowska T. The Missing Link: Cre Pigs for Cancer Research. Front Oncol 2021;11:755746. [PMID: 34692545 DOI: 10.3389/fonc.2021.755746] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Fernandes S, Klein D, Marchetto MC. Unraveling Human Brain Development and Evolution Using Organoid Models. Front Cell Dev Biol 2021;9:737429. [PMID: 34692694 DOI: 10.3389/fcell.2021.737429] [Reference Citation Analysis]
51 Loh JS, Tan LKS, Lee WL, Ming LC, How CW, Foo JB, Kifli N, Goh BH, Ong YS. Do Lipid-based Nanoparticles Hold Promise for Advancing the Clinical Translation of Anticancer Alkaloids? Cancers (Basel) 2021;13:5346. [PMID: 34771511 DOI: 10.3390/cancers13215346] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Moraes KCM, Montagne J. Drosophila melanogaster: A Powerful Tiny Animal Model for the Study of Metabolic Hepatic Diseases. Front Physiol 2021;12:728407. [PMID: 34603083 DOI: 10.3389/fphys.2021.728407] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Formosa MM, Bergen DJM, Gregson CL, Maurizi A, Kämpe A, Garcia-Giralt N, Zhou W, Grinberg D, Ovejero Crespo D, Zillikens MC, Williams GR, Bassett JHD, Brandi ML, Sangiorgi L, Balcells S, Högler W, Van Hul W, Mäkitie O. A Roadmap to Gene Discoveries and Novel Therapies in Monogenic Low and High Bone Mass Disorders. Front Endocrinol (Lausanne) 2021;12:709711. [PMID: 34539568 DOI: 10.3389/fendo.2021.709711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
54 Costard LS, Hosn RR, Ramanayake H, O'Brien FJ, Curtin CM. Influences of the 3D microenvironment on cancer cell behaviour and treatment responsiveness: A recent update on lung, breast and prostate cancer models. Acta Biomater 2021;132:360-78. [PMID: 33484910 DOI: 10.1016/j.actbio.2021.01.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
55 Chennampally P, Sayed-Zahid A, Soundararajan P, Sharp J, Cox GA, Collins SD, Smith RL. A microfluidic approach to rescue ALS motor neuron degeneration using rapamycin. Sci Rep 2021;11:18168. [PMID: 34518579 DOI: 10.1038/s41598-021-97405-1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
56 Schneider MR, Oelgeschlaeger M, Burgdorf T, van Meer P, Theunissen P, Kienhuis AS, Piersma AH, Vandebriel RJ. Applicability of organ-on-chip systems in toxicology and pharmacology. Crit Rev Toxicol 2021;51:540-54. [PMID: 34463591 DOI: 10.1080/10408444.2021.1953439] [Reference Citation Analysis]
57 Saleem S, Kannan RR. Zebrafish: A Promising Real-Time Model System for Nanotechnology-Mediated Neurospecific Drug Delivery. Nanoscale Res Lett 2021;16:135. [PMID: 34424426 DOI: 10.1186/s11671-021-03592-1] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
58 Vijaysarathy C, Babu Sardar Pasha SP, Sieving PA. Of men and mice: Human X-linked retinoschisis and fidelity in mouse modeling. Prog Retin Eye Res 2021;:100999. [PMID: 34390869 DOI: 10.1016/j.preteyeres.2021.100999] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
59 Bellucci L, Montini G, Collino F, Bussolati B. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Pass through the Filtration Barrier and Protect Podocytes in a 3D Glomerular Model under Continuous Perfusion. Tissue Eng Regen Med 2021;18:549-60. [PMID: 34313970 DOI: 10.1007/s13770-021-00374-9] [Reference Citation Analysis]
60 Kang S, Park SE, Huh DD. Organ-on-a-chip technology for nanoparticle research. Nano Converg 2021;8:20. [PMID: 34236537 DOI: 10.1186/s40580-021-00270-x] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
61 Oliveira IM, Fernandes DC, Cengiz IF, Reis RL, Oliveira JM. Hydrogels in the treatment of rheumatoid arthritis: drug delivery systems and artificial matrices for dynamic in vitro models. J Mater Sci Mater Med 2021;32:74. [PMID: 34156535 DOI: 10.1007/s10856-021-06547-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
62 McCollum CR, Bertram JR, Nagpal P, Chatterjee A. Photoactivated Indium Phosphide Quantum Dots Treat Multidrug-Resistant Bacterial Abscesses In Vivo. ACS Appl Mater Interfaces 2021;13:30404-19. [PMID: 34156817 DOI: 10.1021/acsami.1c08306] [Reference Citation Analysis]
63 Garcia de Lomana M, Morger A, Norinder U, Buesen R, Landsiedel R, Volkamer A, Kirchmair J, Mathea M. ChemBioSim: Enhancing Conformal Prediction of In Vivo Toxicity by Use of Predicted Bioactivities. J Chem Inf Model 2021;61:3255-72. [PMID: 34153183 DOI: 10.1021/acs.jcim.1c00451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Triunfol M, Gouveia FC. What's not in the news headlines or titles of Alzheimer disease articles? #InMice. PLoS Biol 2021;19:e3001260. [PMID: 34129637 DOI: 10.1371/journal.pbio.3001260] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 Trivedi P, Liu R, Bi H, Xu C, Rosenholm JM, Åkerfelt M. 3D Modeling of Epithelial Tumors-The Synergy between Materials Engineering, 3D Bioprinting, High-Content Imaging, and Nanotechnology. Int J Mol Sci 2021;22:6225. [PMID: 34207601 DOI: 10.3390/ijms22126225] [Reference Citation Analysis]
66 Soriano L, Khalid T, O'Brien FJ, O'Leary C, Cryan SA. A Tissue-Engineered Tracheobronchial In Vitro Co-Culture Model for Determining Epithelial Toxicological and Inflammatory Responses. Biomedicines 2021;9:631. [PMID: 34199462 DOI: 10.3390/biomedicines9060631] [Reference Citation Analysis]
67 Yadav J, El Hassani M, Sodhi J, Lauschke VM, Hartman JH, Russell LE. Recent developments in in vitro and in vivo models for improved translation of preclinical pharmacokinetics and pharmacodynamics data. Drug Metab Rev 2021;53:207-33. [PMID: 33989099 DOI: 10.1080/03602532.2021.1922435] [Reference Citation Analysis]
68 Belfiore L, Aghaei B, Law AMK, Dobrowolski JC, Raftery LJ, Tjandra AD, Yee C, Piloni A, Volkerling A, Ferris CJ, Engel M. Generation and analysis of 3D cell culture models for drug discovery. Eur J Pharm Sci 2021;163:105876. [PMID: 33989755 DOI: 10.1016/j.ejps.2021.105876] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Khairudin MAS, Mhd Jalil AM, Hussin N. Effects of Polyphenols in Tea (Camellia sinensis sp.) on the Modulation of Gut Microbiota in Human Trials and Animal Studies. Gastroenterology Insights 2021;12:202-16. [DOI: 10.3390/gastroent12020018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
70 Passini E, Zhou X, Trovato C, Britton OJ, Bueno-orovio A, Rodriguez B. The virtual assay software for human in silico drug trials to augment drug cardiac testing. Journal of Computational Science 2021;52:101202. [DOI: 10.1016/j.jocs.2020.101202] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Rafsanjani Nejad P, Shahi Thakuri P, Singh S, Lamichhane A, Heiss J, Tavana H. Toxicity of Combinations of Kinase Pathway Inhibitors to Normal Human Cells in a Three-Dimensional Culture. SLAS Technol 2021;26:255-64. [PMID: 33880947 DOI: 10.1177/24726303211008858] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
72 Rimpiläinen T, Nunes A, Calado R, Fernandes AS, Andrade J, Ntungwe E, Spengler G, Szemerédi N, Rodrigues J, Gomes JP, Rijo P, Candeias NR. Increased antibacterial properties of indoline-derived phenolic Mannich bases. Eur J Med Chem 2021;220:113459. [PMID: 33915373 DOI: 10.1016/j.ejmech.2021.113459] [Reference Citation Analysis]
73 Huang HJ, Lee YH, Hsu YH, Liao CT, Lin YF, Chiu HW. Current Strategies in Assessment of Nanotoxicity: Alternatives to In Vivo Animal Testing. Int J Mol Sci 2021;22:4216. [PMID: 33921715 DOI: 10.3390/ijms22084216] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
74 Ma HL, Urbaczek AC, Zeferino Ribeiro de Souza F, Augusto Gomes Garrido Carneiro Leão P, Rodrigues Perussi J, Carrilho E. Rapid Fabrication of Microfluidic Devices for Biological Mimicking: A Survey of Materials and Biocompatibility. Micromachines (Basel) 2021;12:346. [PMID: 33807118 DOI: 10.3390/mi12030346] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
75 Kreutzer FP, Meinecke A, Schmidt K, Fiedler J, Thum T. Alternative strategies in cardiac preclinical research and new clinical trial formats. Cardiovasc Res 2021:cvab075. [PMID: 33693475 DOI: 10.1093/cvr/cvab075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
76 Sramek JJ, Murphy MF, Adcock S, Stark JG, Cutler NR. Phase 1 Clinical Trials of Small Molecules: Evolution and State of the Art. Rev Recent Clin Trials 2021;16:232-41. [PMID: 33563172 DOI: 10.2174/1574887116666210204125844] [Reference Citation Analysis]
77 Priyadarshini SR, Moses JA, Anandharamakrishnan C. Determining the glycaemic responses of foods: conventional and emerging approaches. Nutr Res Rev 2021;:1-27. [PMID: 33517932 DOI: 10.1017/S0954422421000020] [Reference Citation Analysis]
78 Ntamo Y, Samodien E, Burger J, Muller N, Muller CJF, Chellan N. In vitro Characterization of Insulin-Producing β-Cell Spheroids. Front Cell Dev Biol 2020;8:623889. [PMID: 33585464 DOI: 10.3389/fcell.2020.623889] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
79 Jin M, Yi X, Liao W, Chen Q, Yang W, Li Y, Li S, Gao Y, Peng Q, Zhou S. Advancements in stem cell-derived hepatocyte-like cell models for hepatotoxicity testing. Stem Cell Res Ther 2021;12:84. [PMID: 33494782 DOI: 10.1186/s13287-021-02152-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
80 Ristori T, Sjöqvist M, Sahlgren CM. Ex Vivo Models to Decipher the Molecular Mechanisms of Genetic Notch Cardiovascular Disorders. Tissue Eng Part C Methods 2021;27:167-76. [PMID: 33403934 DOI: 10.1089/ten.TEC.2020.0327] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Giblin KA, Basili D, Afzal AM, Rosenbrier-Ribeiro L, Greene N, Barrett I, Hughes SJ, Bender A. New Associations between Drug-Induced Adverse Events in Animal Models and Humans Reveal Novel Candidate Safety Targets. Chem Res Toxicol 2021;34:438-51. [PMID: 33338378 DOI: 10.1021/acs.chemrestox.0c00311] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
82 Ma C, Peng Y, Li H, Chen W. Organ-on-a-Chip: A New Paradigm for Drug Development. Trends Pharmacol Sci 2021;42:119-33. [PMID: 33341248 DOI: 10.1016/j.tips.2020.11.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 56] [Article Influence: 6.0] [Reference Citation Analysis]
83 Mekky G, Seeds M, Diab AEA, Shehata AM, Ahmed-Farid OA, Alzebdeh D, Bishop C, Atala A. The potential toxic effects of magnesium oxide nanoparticles and valproate on liver tissue. J Biochem Mol Toxicol 2021;35:e22676. [PMID: 33315275 DOI: 10.1002/jbt.22676] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
84 Skenderian S, Park G, Jang C. Organismal Fructose Metabolism in Health and Non-Alcoholic Fatty Liver Disease. Biology (Basel). 2020;9. [PMID: 33218081 DOI: 10.3390/biology9110405] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
85 Kim J, Kong JS, Han W, Kim BS, Cho DW. 3D Cell Printing of Tissue/Organ-Mimicking Constructs for Therapeutic and Drug Testing Applications. Int J Mol Sci 2020;21:E7757. [PMID: 33092184 DOI: 10.3390/ijms21207757] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
86 Miller JM, Meki MH, Ou Q, George SA, Gams A, Abouleisa RRE, Tang XL, Ahern BM, Giridharan GA, El-Baz A, Hill BG, Satin J, Conklin DJ, Moslehi J, Bolli R, Ribeiro AJS, Efimov IR, Mohamed TMA. Heart slice culture system reliably demonstrates clinical drug-related cardiotoxicity. Toxicol Appl Pharmacol 2020;406:115213. [PMID: 32877659 DOI: 10.1016/j.taap.2020.115213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
87 Bahadoran Z, Mirmiran P, Kashfi K, Ghasemi A. Importance of Systematic Reviews and Meta-analyses of Animal Studies: Challenges for Animal-to-Human Translation. J Am Assoc Lab Anim Sci 2020;59:469-77. [PMID: 32727637 DOI: 10.30802/AALAS-JAALAS-19-000139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
88 Dearden JC. Rodent LD50 Tests: Can We Make Reparation? International Journal of Quantitative Structure-Property Relationships 2020;5:1-5. [DOI: 10.4018/ijqspr.2020070101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
89 Deb B, Shah H, Goel S. Current global vaccine and drug efforts against COVID-19: Pros and cons of bypassing animal trials. J Biosci 2020;45:82. [PMID: 32554907 [PMID: 32554907 DOI: 10.1007/s12038-020-00053-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 5.5] [Reference Citation Analysis]
90 Cassotta M, Forbes-Hernández TY, Calderón Iglesias R, Ruiz R, Elexpuru Zabaleta M, Giampieri F, Battino M. Links between Nutrition, Infectious Diseases, and Microbiota: Emerging Technologies and Opportunities for Human-Focused Research. Nutrients 2020;12:E1827. [PMID: 32575399 DOI: 10.3390/nu12061827] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
91 Van Norman GA. Limitations of Animal Studies for Predicting Toxicity in Clinical Trials: Part 2: Potential Alternatives to the Use of Animals in Preclinical Trials. JACC Basic Transl Sci 2020;5:387-97. [PMID: 32363250 DOI: 10.1016/j.jacbts.2020.03.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
92 Raja SG. Invited Commentary on "the translation of surgical animal models to human clinical research: A cross sectional study". Int J Surg 2020;78:7-8. [PMID: 32304891 DOI: 10.1016/j.ijsu.2020.04.002] [Reference Citation Analysis]
93 Schledwitz A, Xie G, Raufman JP. Exploiting unique features of the gut-brain interface to combat gastrointestinal cancer. J Clin Invest 2021;131:143776. [PMID: 33998603 DOI: 10.1172/JCI143776] [Cited by in F6Publishing: 4] [Reference Citation Analysis]